arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

Rafael Holdings, Inc.

RFL
$1.06 ▼ -0.04 (-3.62%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
12 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

Rafael Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $54.5M
Dividend Yield —
Revenue Growth -4.7% ↘
Op. Margin None
ROIC -50.4% ↘
FCF / Share $-0.58 ↗
Trailing P/E —
Price / Book 0.8x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

12-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$874.00K
↓ -4.7% —
Net Income Profit after all expenses
$-29.64M
↑ +2.9% —
Operating Margin Operating profit as % of sales
-172.4%
↓ -27.0% —
FCF / Share Free cash flow per share
$-0.58
↑ +9.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑
16
Cash Quality ↑
64

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 12 years · 42 quarters